Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
317.75
+4.53 (1.45%)
At close: May 19, 2026, 4:00 PM EDT
318.10
+0.35 (0.11%)
After-hours: May 19, 2026, 7:33 PM EDT
Stryker Revenue
Stryker had revenue of $6.02B in the quarter ending March 31, 2026, with 2.63% growth. This brings the company's revenue in the last twelve months to $25.27B, up 8.84% year-over-year. In the year 2025, Stryker had annual revenue of $25.12B with 11.16% growth.
Revenue (ttm)
$25.27B
Revenue Growth
+8.84%
P/S Ratio
4.82
Revenue / Employee
$451,250
Employees
56,000
Market Cap
121.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.12B | 2.52B | 11.16% |
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | 14.88B | 1.28B | 9.43% |
| Dec 31, 2018 | 13.60B | 1.16B | 9.30% |
| Dec 31, 2017 | 12.44B | 1.12B | 9.88% |
| Dec 31, 2016 | 11.33B | 1.38B | 13.86% |
| Dec 31, 2015 | 9.95B | 271.00M | 2.80% |
| Dec 31, 2014 | 9.68B | 654.00M | 7.25% |
| Dec 31, 2013 | 9.02B | 364.00M | 4.20% |
| Dec 31, 2012 | 8.66B | 350.00M | 4.21% |
| Dec 31, 2011 | 8.31B | 987.00M | 13.48% |
| Dec 31, 2010 | 7.32B | 597.00M | 8.88% |
| Dec 31, 2009 | 6.72B | 4.80M | 0.07% |
| Dec 31, 2008 | 6.72B | 717.70M | 11.96% |
| Dec 31, 2007 | 6.00B | 853.30M | 16.58% |
| Dec 31, 2006 | 5.15B | 538.30M | 11.68% |
| Dec 31, 2005 | 4.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 45.13B |
| Medtronic | 35.48B |
| GE HealthCare Technologies | 20.98B |
| Boston Scientific | 20.61B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
SYK News
- 18 hours ago - BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem - Business Wire
- 1 day ago - AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study - Business Wire
- 6 days ago - Stryker Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - GlobeNewsWire
- 12 days ago - Stryker declares an $0.88 per share quarterly dividend - GlobeNewsWire
- 13 days ago - Stryker Transcript: AGM 2026 - Transcripts
- 15 days ago - Stryker price target lowered to $330 from $380 at Truist - TheFly
- 15 days ago - Stryker price target lowered to $394 from $469 at Barclays - TheFly